Showing results (2371-2380 of 3,162) with videos related to

Sort By:
Pageof 317
Neuro-Oncology|December 30, 2022
Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growthAsimina Zisi, Dimitris C Kanellis, Simon Moussaud, et al.
Neuro-Oncology|January 2, 2023
Wnt signaling regulates MFSD2A-dependent drug delivery through endothelial transcytosis in gliomaYuan Xie, Liqun He, Yanyu Zhang, et al.
Neuro-Oncology|January 12, 2023
Hypothalamic-pituitary-gonadal function, pubertal development, and fertility outcomes in male and female medulloblastoma survivors: a single-center experienceEve Stern, Michal Ben-Ami, Noah Gruber, et al.
Neuro-Oncology|December 21, 2022
Alternative lengthening of telomeres (ALT) in pediatric high-grade gliomas can occur without ATRX mutation and is enriched in patients with pathogenic germline mismatch repair (MMR) variantsJennifer L Stundon, Heba Ijaz, Krutika S Gaonkar, et al.
Neuro-Oncology|May 31, 2022
Hippocampal avoidance prophylactic cranial irradiation (HA-PCI) for small cell lung cancer reduces hippocampal atrophy compared to conventional PCIMichiel B de Ruiter, Paul F C Groot, Sabine Deprez, et al.
Neuro-Oncology|June 2, 2022
Phase II study of alisertib as a single agent for treating recurrent or progressive atypical teratoid/rhabdoid tumorSanthosh A Upadhyaya, Olivia Campagne, Catherine A Billups, et al.
Neuro-Oncology|December 6, 2022
Association of circulating markers with cognitive decline after radiation therapy for brain metastasisKristin Huntoon, S Keith Anderson, Karla V Ballman, et al.
Neuro-Oncology|May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoterMichael Lim, Michael Weller, Ahmed Idbaih, et al.
Neuro-Oncology|April 8, 2022
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)Ami V Desai, Giles W Robinson, Karen Gauvain, et al.
Neuro-Oncology|July 28, 2022
Cross-platform analysis reveals cellular and molecular landscape of glioblastoma invasionAnn T Chen, Yang Xiao, Xiangjun Tang, et al.
Pageof 317